MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Cabozantinib

  1. Home
  2. Drugs
  3. Cabozantinib
  4. Clinical Trials

Clinical Trials Related to Cabozantinib

Related studies linked through entity extraction aliases.

NCT01441947

Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer

Status
COMPLETED
Phase
PHASE2

NCT01428219

Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone

Status
TERMINATED
Phase
PHASE2

NCT01347788

Cabozantinib (XL184) in Men With Castrate-Resistant Prostate Cancer

Status
COMPLETED
Phase
PHASE1

NCT01068782

Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse

Status
TERMINATED
Phase
PHASE2

NCT00940225

Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

Status
COMPLETED
Phase
PHASE2
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.